Primary Job Title Chief Medical Officer Primary Organization 
Advanced Cell Diagnostics
Location San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Male
Website www.acdbio.com/ LinkedIn View on LinkedIn
Rob Monroe brings to ACD a record of success providing medical leadership for both venture-backed and public companies in the clinical diagnostics industry. Most recently, he served as Medical Director and Vice President of Laboratory Operations for Veracyte (VCYT), a diagnostics company focused on molecular cytology, where he led the company’s
CLIA laboratories, including oversight of the highly successful Afirma® Thyroid FNA Analysis and recent launch of the Percepta™ Bronchial Genomic Classifer. Prior to Veracyte, Rob Monroe served as Chief Medical Officer of BioImagene (acquired by Ventana, a member of the Roche Group, in 2010), a leading provider of imaging solutions for anatomic pathology and clinical diagnostics where he headed the company’s efforts to develop software applications for pathologists, including multiple FDA-cleared algorithms for immunohistochemistry analysis. Rob Monroe was also Co-Founder and Chief Medical Officer of OncoMDx, a Palo Alto-based molecular diagnostics laboratory later acquired by CORE Diagnostics to support expansion of next generation diagnostics in India. Prior to joining BioImagene, Rob Monroe served as a Medical Director for Central Coast Pathology where he led cytopathology and molecular pathology programs. Rob Monroe is board certified in anatomic pathology, clinical pathology, and cytopathology. He holds MD and PhD degrees from Harvard Medical School and completed his pathology training at Stanford and UCLA.
